Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Bulent Undar
Dokuz Eylül University
88Publications
11H-index
342Citations
Publications 88
Newest
Published on Nov 26, 2018in Hematology 1.32
Guray Saydam18
Estimated H-index: 18
(Ege University),
Ibrahim C. Haznedaroglu34
Estimated H-index: 34
+ 15 AuthorsMehmet Sonmez11
Estimated H-index: 11
(Karadeniz Technical University)
ABSTRACTObjectives: This report presents final results (24 months of follow-up) from the first prospective, national study of frontline nilotinib in chronic myeloid leukemia (CML) patients in Turkey.Methods: Patients with newly diagnosed Philadelphia chromosome–positive CML in chronic phase (CML-CP; N = 112) received nilotinib 300 mg twice daily. The primary endpoint, which was the cumulative rate of major molecular response (MMR; BCR-ABL1 ≤ 0.1% on the International Scale [BCR-ABL1IS]) by 12 mo...
Source Cite
Published on Oct 1, 2018in Journal of Laboratory Physicians
Serife Medeni Solmaz1
Estimated H-index: 1
,
Ozcan Uzun + 8 AuthorsMehmet Ali Özcan15
Estimated H-index: 15
(Dokuz Eylül University)
BACKGROUND: Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies. MATERIALS AND METHODS: We retrospectively examined the PLR, NLR, and MLR in a cohort of 186 newly diagnosed multiple myeloma (MM) patients. This study investigated the prognostic relevance of NLR, PLR, and MLR in MM patients. NLR, PLR, and MLR were ca...
Source Cite
Serife Medeni Solmaz1
Estimated H-index: 1
,
Selda Kahraman1
Estimated H-index: 1
(Medical Park)
+ 8 AuthorsBulent Undar11
Estimated H-index: 11
(Dokuz Eylül University)
Peripheral blood is the prefered source for hematopoietic stem cells for hematopoietic stem cell transplantation. The efficiency of peripheral blood stem cell (PBSC) collection can vary among devices. In this study we aimed to compare feasibility and effectivity of apheresis procedures of the different systems. Two apheresis systems [Com.Tec (Fresenius Healthcare) and Spectra Optia (Caridian BCT)] were used in our center for the collection of PBSCs for autologous and allogeneic transplantation. ...
Source Cite
Published on Jun 20, 2018in Turkish Journal of Hematology 0.78
Serife Solmaz Medeni1
Estimated H-index: 1
,
Doğuş Türkyılmaz + 8 AuthorsInci Alacacioglu8
Estimated H-index: 8
Source Cite
Published on Sep 30, 2017in Cukurova Medical Journal
Nurhilal Buyukkurt2
Estimated H-index: 2
,
Güner Hayri Özsan5
Estimated H-index: 5
+ 6 AuthorsBulent Undar11
Estimated H-index: 11
Amac: Bircok faktor hematopoetik kok hucre (HKH) engraftmanini etkiler. Bu calismada hematolojik kanseri olan hastalarda kemik iligindeki myelofibrozis ve anjiogenezisin engraftman uzerine etkisi arastirilmistir. Gerec ve Yontem: Otolog kok hucre nakli yapilan 34 hasta (20 erkek, 14 kadin) verileri degerlendirildi. Nakilden onceki son kemik iligindeki fibrozis 0-3 arasinda derecelendirildi, anjiogenezis stereolojik metod ile olculdu. Hastalar anjiogenezis parametrelerinin yogunluguna gore de iki...
Source Cite
Published on Sep 21, 2016in Expert Opinion on Pharmacotherapy 3.04
Guray Saydam18
Estimated H-index: 18
(Ege University),
Ibrahim C. Haznedaroglu34
Estimated H-index: 34
(Hacettepe University)
+ 15 AuthorsMehmet Sonmez11
Estimated H-index: 11
(Karadeniz Technical University)
ABSTRACTObjective: Nilotinib is a BCR-ABL1 tyrosine kinase inhibitor approved for the treatment of patients with chronic myeloid leukemia in chronic phase (CML-CP). This study was the first prospective evaluation of the efficacy and safety of nilotinib in Turkish patients with newly diagnosed CML-CP. The primary endpoint of the study was the rate of major molecular response (MMR; BCR-ABL1 ≤ 0.1% on the International Scale [BCR-ABL1IS]) by 12 months.Methods: Patients with newly diagnosed CML-CP w...
3 Citations Source Cite
Published on Apr 1, 2016in Experimental Hematology 2.46
Ayşe Pınar Erçetin1
Estimated H-index: 1
(Dokuz Eylül University),
Mehmet Ali Özcan15
Estimated H-index: 15
(Dokuz Eylül University)
+ 6 AuthorsBulent Undar11
Estimated H-index: 11
(Dokuz Eylül University)
Multiple myeloma (MM) is a hematologic cancer characterized by malignant proliferation of plasma cells and their precursors. Immunosuppressive CD4+CD25+Foxp3+ regulatory T (Treg) cells are increased in the peripheral blood of patients with MM. On the basis of this finding, we sought to evaluate the ex vivo effect of CD4+CD25+Foxp3+ Treg cells on the anti-tumor effect of the proteosome inhibitor bortezomib on MM cells. We collected peripheral blood and bone marrow aspiration samples from 20 patie...
1 Citations Source Cite
123456789